Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS

Background: The COVID-19 pandemic reached Germany in spring 2020. No proven treatment for SARS-CoV-2 was available at that time, especially for severe COVID-19-induced ARDS. We determined whether the infusion of mesenchymal stromal cells (MSCs) would help to improve pulmonary function and overall ou...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of intensive care medicine 2021-06, Vol.36 (6), p.681-688
Hauptverfasser:	Häberle, Helene, Magunia, Harry, Lang, Peter, Gloeckner, Henning, Körner, Andreas, Koeppen, Michael, Backchoul, Tamam, Malek, Nisar, Handgretinger, Rupert, Rosenberger, Peter, Mirakaj, Valbona
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Cohort Studies COVID-19 - complications COVID-19 - mortality COVID-19 - therapy Critical Care Female Germany Humans Male Mesenchymal Stem Cell Transplantation Middle Aged Original Research Respiration, Artificial Respiratory Distress Syndrome - mortality Respiratory Distress Syndrome - therapy Respiratory Distress Syndrome - virology Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!